Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Body Composition and Metabolic Changes During Antipsychotic Treatment
2006-001661-41Phase 4Terminated
- Sponsor
- Karolinska University Hospital
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in schizophrenia comparing Sertindole monotherapy with Olanzapine monotherapy (2 arms). Primary endpoint: Change in body composition. Started Mar 2006; status: terminated.
02
Drugs
sertindoleolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2006-001661-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001661-41.